Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection

BACKGROUND: Direct-acting antivirals (DAA) as curative therapy for hepatitis C virus (HCV) infection offer >95% sustained virologic response (SVR), including in patients with human immunodeficiency virus (HIV) infection. Despite improved safety and efficacy of HCV treatment, challenges remain, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Collins, Lauren F, Chan, Austin, Zheng, Jiayin, Chow, Shein-Chung, Wilder, Julius M, Muir, Andrew J, Naggie, Susanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753271/
https://www.ncbi.nlm.nih.gov/pubmed/29308413
http://dx.doi.org/10.1093/ofid/ofx264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5753271/
https://www.ncbi.nlm.nih.gov/pubmed/29308413
http://dx.doi.org/10.1093/ofid/ofx264

Ejemplares similares